This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Mussi, C. Articles by Salvioli, G. Search for Related Content PubMed PubMed Citation Articles by Mussi, C. Articles by Salvioli, G. Social Bookmarking                         What's this?

Importance of Serum Anticholinergic Activity in the Assessment of Elderly Patients with Delirium

Rosaria Ferrari, MD

Stefania Ascari, MD

Gianfranco Salvioli, MD

To evaluate the importance of serum anticholinergic activity (SAA) in elderly patients who developed delirium fol lowing hospital admission, we performed a cross-sectional study with consecutively referred inpatients in a university geriatric medical ward. Sixty-one patients aged 66 to 95 years (mean age: 79.2 ± 11.6; 54% females) were recruited. Delirium was assessed by means of the Confusion Assessment Method, SAA determination, questionnaire for cur rent drug treatment, past medical history and clinical examination, and blood chemistries. Patients were divided into two groups according to the absence (N = 49) or the presence (N = 12) of delirium. Delirious patients showed a significantly higher SAA (23.0 vs 3.9 pmol/mL atropine equivalents, P < .004); they were using antibiotics (P < .05), neuroleptics (P < .002), barbiturates (P < .004), and benzodiazepines (P < .005) more frequently. Subjects with delir ium were more likely to have infections and a lower Body Mass Index; they had higher plasma glucose and creatinine. The multivariate analysis identified SAA and use of neuroleptics, and benzodiazepines as the most important fea tures independently associated with delirium. SAA may be a suitable marker for identifying people at risk of developing delirium. Moreover, neuroleptics and benzodiazepines must be carefully used in the elderly because of their relationship with the onset of delirium. (J Geriatr Psychiatry Neurol 1999; 12:82-86).

Journal of Geriatric Psychiatry and Neurology, Vol. 12, No. 2, 82-86 (1999)
DOI: 10.1177/089198879901200208


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				V. Camus, R. Gonthier, G. Dubos, P. Schwed, and I. Simeone Etiologic and Outcome Profiles in Hypoactive and Hyperactive Subtypes of Delirium J Geriatr Psychiatry Neurol, April 1, 2000; 13(1): 38 - 42. [Abstract] [PDF]